Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Lanfear

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Cardiovascular Drugs and Therapy|March 7, 2007
Genetic variation in the B-type natiuretic peptide pathway affects BNP levelsDavid E Lanfear, Joshua M Stolker, Sharon Marsh, et al.
Annals of Biomedical Engineering|June 10, 2026
Oxygen Transport Impairment in the Failing Heart: A Histology-Image-Based Computational AnalysisHaifeng Wang, Mythri Tumbalam Gooty, David E Lanfear, et al.
Cardiology and Therapy|August 19, 2020
A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection FractionDavid E Lanfear, Kelsey R Neaton, Chen Lu, et al.
American Heart Journal|December 9, 2008
Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency departmentZehra Jaffery, Richard Nowak, Nabil Khoury, et al.
Journal of Cardiac Failure|October 23, 2024
Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor-Associated Reduction in Heart Failure HospitalizationsShana D R Littleton, David E Lanfear, Michael P Dorsch, et al.
Pain Physician|May 23, 2014
Policies and events affecting prescription opioid use for non-cancer pain among an insured patient populationBrian K Ahmedani, Edward L Peterson, Karen E Wells, et al.
Genome Medicine|June 17, 2011
Factors influencing patient willingness to participate in genetic research after a myocardial infarctionDavid E Lanfear, Philip G Jones, Sharon Cresci, et al.
International Journal of Cardiology|January 14, 2014
Gap between clinical guidelines and practice: the case of aldosterone-antagonists in patients with myocardial infarctionSupriya Shore, Thomas M Maddox, Fengming Tang, et al.
Journal of Cardiac Failure|March 3, 2018
Cardiopulmonary Exercise Measures of Men and Women with HFrEF Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (FIT-CPX) ProjectJonathan K Ehrman, Clinton A Brawner, Ali Shafiq, et al.
American Heart Journal|August 28, 2007
Connexin37 (GJA4) genotype predicts survival after an acute coronary syndromeDavid E Lanfear, Philip G Jones, Sharon Marsh, et al.
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Cardiovascular Drugs and Therapy|March 7, 2007
Genetic variation in the B-type natiuretic peptide pathway affects BNP levelsDavid E Lanfear, Joshua M Stolker, Sharon Marsh, et al.
Annals of Biomedical Engineering|June 10, 2026
Oxygen Transport Impairment in the Failing Heart: A Histology-Image-Based Computational AnalysisHaifeng Wang, Mythri Tumbalam Gooty, David E Lanfear, et al.
Cardiology and Therapy|August 19, 2020
A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection FractionDavid E Lanfear, Kelsey R Neaton, Chen Lu, et al.
American Heart Journal|December 9, 2008
Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency departmentZehra Jaffery, Richard Nowak, Nabil Khoury, et al.
Journal of Cardiac Failure|October 23, 2024
Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor-Associated Reduction in Heart Failure HospitalizationsShana D R Littleton, David E Lanfear, Michael P Dorsch, et al.
Pain Physician|May 23, 2014
Policies and events affecting prescription opioid use for non-cancer pain among an insured patient populationBrian K Ahmedani, Edward L Peterson, Karen E Wells, et al.
Genome Medicine|June 17, 2011
Factors influencing patient willingness to participate in genetic research after a myocardial infarctionDavid E Lanfear, Philip G Jones, Sharon Cresci, et al.
International Journal of Cardiology|January 14, 2014
Gap between clinical guidelines and practice: the case of aldosterone-antagonists in patients with myocardial infarctionSupriya Shore, Thomas M Maddox, Fengming Tang, et al.
Journal of Cardiac Failure|March 3, 2018
Cardiopulmonary Exercise Measures of Men and Women with HFrEF Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (FIT-CPX) ProjectJonathan K Ehrman, Clinton A Brawner, Ali Shafiq, et al.
American Heart Journal|August 28, 2007
Connexin37 (GJA4) genotype predicts survival after an acute coronary syndromeDavid E Lanfear, Philip G Jones, Sharon Marsh, et al.
Pageof 18